How Should We Respond to Health Sector Emissions That Exacerbate Climate Change and Inequity?

AMA J Ethics

Clinical assistant professor of surgery in the School of Medicine and Health Sciences at the George Washington University in Washington, DC, and co-director of the university's Climate and Health Institute.

Published: October 2022

A warming climate poses substantial risk to public health and worsens existing health inequity. As a contributor to greenhouse gas emissions and air pollution, the health sector has obligations and ample opportunities to protect health by decreasing waste and motivating more system-wide sustainable clinical practices. Such efforts will have important ethical implications for health equity.

Download full-text PDF

Source
http://dx.doi.org/10.1001/amajethics.2022.927DOI Listing

Publication Analysis

Top Keywords

health sector
8
health
5
respond health
4
sector emissions
4
emissions exacerbate
4
exacerbate climate
4
climate change
4
change inequity?
4
inequity? warming
4
warming climate
4

Similar Publications

Background: Inhalational anesthetic agents are a major source of potent greenhouse gases in the medical sector, and reducing their emissions is a readily addressable goal. Nitrous oxide (NO) has a long environmental half-life relative to carbon dioxide combined with a low clinical potency, leading to relatively large amounts of NO being stored in cryogenic tanks and H cylinders for use, increasing the chance of pollution through leaks. Building on previous findings, Stanford Health Care's (SHC's) NO emissions were analyzed at 2 campuses and targeted for waste reduction as a precursor to system-wide reductions.

View Article and Find Full Text PDF

Observation-based verification of regional/national methane (CH) emission trends is crucial for transparent monitoring and mitigation strategy planning. Although surface observations track the global and sub-hemispheric emission trends well, their sparse spatial coverage limits our ability to assess regional trends. Dense satellite observations complement surface observations, offering a valuable means to validate emission trends, especially in regions where emissions changes are substantial but debated.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

National Ageing Research Institute, Melbourne, VIC, Australia.

Background: Prior to formulating an effective national dementia plan in Vietnam, reliable information on current situation of dementia care, treatment and support in Vietnam was needed. This study was conducted to describe Vietnam's response to dementia at three levels: individual (consumers and providers); health and social care organisations; and national healthcare system to guide the plan development.

Method: Guided by the "Towards a dementia plan: a WHO guide", a comprehensive situational analysis was conducted, focusing on Policy, Service Delivery and Epidemiological assessments.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Universidad de Buenos Aires Facultad de Psicologia, caba, Buenos aires, Argentina.

Background: The stereotypes that exist in people function as a bias that conditions their behavior. The presence of negative stereotypes towards older people has negative consequences both at an individual level and at a social level, since discriminatory practices occur towards this group. Therefore, the present project arises to respond a social problem detected by the National Institute of Social Services for Retirees and Pensioners (PAMI) of LaMatanza, Buenos Aires Argentina who had contacted a group of researchers of National Council of Scientific and Technical Research (CONICET) Argentina, to provide an answer to this problem in the region, were few studies were done about this subject.

View Article and Find Full Text PDF

Background: The Maintain Your Brain (MYB) randomised controlled trial (RCT) examined the effect of a multi-domain internet-based dementia prevention program against a control group (information only) over three years among Australians aged 55-77 years. A cost-effective analysis (CEA) quantified the differences in costs (direct healthcare and program costs) and effectiveness outcomes between the intervention and control groups from a health care sector perspective.

Method: An economic evaluation was conducted alongside the MYB trial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!